AXS Investments’s ResMed RMD Stock Holding History

AXS Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$68.7K	Sell	306 -65	-18%	-$16.2K	0.03%	146
2025 Q4	$89.4K	Sell	371 -64	-15%	-$16.4K	0.03%	152
2025 Q3	$119K	Buy	+435	New	+$119K	0.04%	146
2023 Q4	–	Sell	-475	Closed	-$70.2K	–	426
2023 Q3	$70.2K	Sell	475 -50	-10%	-$9.04K	0.02%	327
2023 Q2	$115K	Buy	525 +20	+4%	+$4.46K	0.03%	293
2023 Q1	$111K	Sell	505 -62	-11%	-$13.5K	0.04%	254
2022 Q4	$118K	Buy	+567	New	+$125K	0.04%	225
2022 Q2	–	Sell	-1,257	Closed	-$305K	–	221
2022 Q1	$305K	Sell	1,257 -1,111	-47%	-$269K	0.12%	110
2021 Q4	$617K	Buy	+2,368	New	+$614K	0.15%	103
2021 Q2	–	Sell	-1,610	Closed	-$312K	–	174
2021 Q1	$312K	Buy	+1,610	New	+$323K	0.11%	139

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AXS Investments's RMD Position: Q1 2026 in Review

AXS Investments reduced its ResMed (RMD) stake by 18% in Q1 2026, selling an estimated $16.2K and leaving 306 shares worth $68.7K. The position accounts for 0.03% of the portfolio, ranked #146.

AXS Investments first reported a position in RMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $617K in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

AXS Investments held 306 shares of ResMed worth $68.7K as of Q1 2026.
AXS Investments sold 65 ResMed shares in Q1 2026, an estimated $16.2K.
ResMed made up 0.03% of AXS Investments's portfolio in Q1 2026, its #146 holding.
AXS Investments first reported a position in ResMed in Q1 2021 and has held it in 10 quarters since.
AXS Investments's ResMed position peaked at $617K in Q4 2021.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.